---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-033696"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2022-11-25T23:59:59+00:00"
generated_at: "2026-06-21T12:58:36.735961+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated Sciences receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Closing bid price below $1.00 for 30 consecutive business days (Oct 10 - Nov 11, 2022).
- Received Nasdaq notification on Nov 21, 2022; stock continues trading under NVOS.
- Must regain compliance by May 22, 2023, with closing bid >= $1.00 for 10 consecutive days.
- May qualify for additional 180-day cure period if other listing requirements are met.
- Company will monitor bid price and consider options to regain compliance.

## SEC filing metadata
- accession: 0001493152-22-033696
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2022-11-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000149315222033696/0001493152-22-033696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000149315222033696/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-033696
- JSON: https://secwatch.observer/filing/0001493152-22-033696.json
- Plain text: https://secwatch.observer/filing/0001493152-22-033696.txt

## Key facts
- Listing & Compliance Notices
  Novo Integrated Sciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: November 21, 2022, Novo Integrated Sciences, Inc., a Nevada corporation (the “Company”), received a notification letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq. Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency co
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315222033696/0001493152-22-033696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.